Comprehensive Regulatory Reform From The Bottom Up: The Case Of 340B

Using the ruse of “price negotiation”, the proponents of the Build Back Better legislation are pushing an ill-fated drug price control plan. Patients will bear exceptionally large costs should their idea of government-directed prices become law. These costs will include lower health outcomes due to … Continue reading Comprehensive Regulatory Reform From The Bottom Up: The Case Of 340B